Edition:
United States

People: Bristol-Myers Squibb Co (BMY)

BMY on New York Consolidated

63.36USD
22 Sep 2017
Change (% chg)

$0.03 (+0.05%)
Prev Close
$63.33
Open
$63.33
Day's High
$63.55
Day's Low
$63.04
Volume
3,667,202
Avg. Vol
6,992,098
52-wk High
$63.74
52-wk Low
$46.01

Bancroft, Charles 

Mr. Charles A. Bancroft is Chief Financial Officer and Executive Vice President - Global Business Operations of the Company. He has been appointed as Executive Vice President effective October 19, 2011. He joined Bristol-Myers Squibb in 1984 and has since held positions of increasing responsibility within the finance organization, including international assignments, senior leadership positions in the global pharmaceutical business and also with ConvaTec. He received a B.S. in Accounting from Drexel University, his M.B.A. in Finance from Temple University and is a certified public accountant.

Basic Compensation

Total Annual Compensation, USD 2,496,770
Restricted Stock Awards, USD 4,013,210
Long-Term Incentive Plans, USD --
All Other, USD 461,714
Fiscal Year Total, USD 6,971,690

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Giovanni Caforio

16,933,900

Charles Bancroft

6,971,690

Louis Schmukler

--

Ann Judge

--

Thomas Lynch

322,500

Sandra Leung

5,441,800
As Of  30 Dec 2016